Peter von Dadelszen to Biomarkers
This is a "connection" page, showing publications Peter von Dadelszen has written about Biomarkers.
Connection Strength
0.181
-
Characterization of maternal plasma biomarkers associated with delivery of small and large for gestational age infants in the MIREC study cohort. PLoS One. 2018; 13(11):e0204863.
Score: 0.036
-
Activated protein C as disease-modifying therapy in antenatal preeclampsia: An open-label, single arm safety and efficacy trial. Pregnancy Hypertens. 2018 Jul; 13:121-126.
Score: 0.035
-
Creating biobanks in low and middle-income countries to improve knowledge - The PREPARE initiative. Pregnancy Hypertens. 2018 Jul; 13:62-64.
Score: 0.035
-
Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique. Pregnancy Hypertens. 2018 Jan; 11:26-31.
Score: 0.034
-
Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review. Hypertension. 2017 12; 70(6):1228-1237.
Score: 0.033
-
Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies. Aust N Z J Obstet Gynaecol. 2019 02; 59(1):89-95.
Score: 0.009